Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...

The Chronicle spoke with Duke alumnus and professor Robert Califf about the recent “Make America Healthy Again” report and ...

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the ...

Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple ...

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).   “As with all drugs, FDA continues to ...

"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical ...

The U.S. Food and Drug Administration has rolled out a new AI assistant, Elsa, that it says will increase efficiency at its ...

The position of commissioner in Food and Drug Administration (FDA) has been lying vacant since the retirement of Hashmat Ali Yauto in February, an RTI activist said on Saturday, questioning the delay ...

A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its current label indicates.